Helix Biopharma Corp. HBPCF
—
1.71
0.00
0.00%
as of 24 Sep
- Market cap
- —
- P/E
- 0.0×
Follow HBPCF
Growth Flags
show if company had growth for consecutive years
| Jul '16 | Jul '17 | Jul '18 | Jul '19 | Jul '20 | Jul '21 | Jul '22 | Jul '23 | Jul '24 | Jul '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
3.25 | 0.77 | 0.29 | 0.16 | 2.42 | 1.04 | 1.08 | 0.53 | 0.92 | 0.13 |
Net Debt/EBITDA |
0.38 | 0.09 | 0.04 | 0.03 | 0.50 | 0.22 | 0.54 | 0.13 | 0.12 | (0.05) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 38.97% | 0.00% | 0.00% | 0.00% | 1.78% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (1.14) | 0.00 | 0.00 | 0.00 | 0.02 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.92 | 0.92 | 0.87 | 0.73 | 1.20 | 1.16 | 0.99 | 0.88 | 0.56 | 0.74 |
Capex/Depreciation |
(0.30) | (1.65) | (0.32) | (0.03) | (0.08) | 0.00 | 0.00 | (0.38) | (1.00) | 1.69 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (179.15%) | (640.97%) | 1,117.75% | 309.16% | 5,104.05% | (1,124.71%) | 1,227.10% | 2,482.68% | 1,961.01% | (67.19%) | |
| (146.70%) | (302.84%) | (530.59%) | (705.79%) | (306.60%) | (184.57%) | (168.67%) | (252.98%) | (731.94%) | (51.21%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (21.21%) |
Return on Tangible Assets |
(305.46%) | 59,379.69% | 564.79% | 229.39% | (317.93%) | (4,208.67%) | (2,050.36%) | 744.37% | 10,295.32% | 185.69% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.98 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.39) | (0.39) | (0.30) | (0.20) | (0.32) | (0.26) | (0.17) | (0.11) | (0.09) | (0.05) |
Cash per Share |
0.16 | 0.04 | 0.01 | 0.01 | 0.12 | 0.10 | 0.09 | 0.02 | 0.02 | 0.00 |
Shareholders Equity per Share |
0.14 | 0.00 | (0.06) | (0.12) | 0.09 | (0.04) | 0.01 | (0.02) | 0.00 | 0.20 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.14 | 0.00 | (0.06) | (0.12) | 0.09 | (0.04) | 0.01 | (0.02) | 0.00 | 0.20 |
Free Cash Flow |
(6.70) | (7.18) | (5.95) | (4.18) | (8.06) | (7.31) | (5.13) | (4.12) | (3.85) | (2.73) |
Working Capital |
2.21 | (0.38) | (1.49) | (2.67) | 2.03 | 0.11 | 0.22 | (0.65) | (0.09) | (2.01) |
Capital Expenditures |
(0.03) | (0.16) | (0.04) | 0.00 | (0.01) | — | — | 0.00 | (0.01) | 0.01 |
Net Current Asset Value |
2.21 | (0.38) | (1.49) | (2.67) | 2.03 | (1.13) | 0.22 | (0.65) | (0.09) | (2.01) |
| Other line items | ||||||||||
Quick Ratio |
3.18 | 0.69 | 0.25 | 0.12 | 2.29 | 1.01 | 1.04 | 0.46 | 0.72 | 0.06 |
Depreciation/Fixed assets |
0.57 | 0.27 | 0.44 | 0.49 | 2.32 | 4.24 | 0.33 | 0.39 | 0.42 | 2.48 |
Cash ROIC |
(133.29%) | (1,111.47%) | 680.30% | 188.09% | (151.29%) | (248.96%) | (183.28%) | 15,460.07% | (529.95%) | (23.99%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.39) | (0.38) | (0.30) | (0.20) | (0.32) | (0.26) | (0.17) | (0.11) | (0.09) | (0.05) |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.39 | 0.42 | 0.36 | 0.23 | 0.18 | 0.21 | 0.25 | 0.13 | 0.04 | 0.06 |
Average Payables |
0.38 | 0.81 | 1.33 | 1.93 | 1.67 | 1.10 | 0.81 | 0.56 | 0.91 | 1.61 |
Average Assets |
4.96 | 2.51 | 1.28 | 0.81 | 2.18 | 3.42 | 3.07 | 1.85 | 0.93 | 7.29 |
Average Common Equity |
4.07 | 1.19 | (0.61) | (1.84) | (0.13) | 0.56 | (0.42) | (0.19) | (0.35) | 5.55 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates